“P42 | Efficacy and Safety of Roxadustat in Patients With Non-Dialysis-Dependent Chronic Kidney Disease With or Without Inflammation: Pooled Analysis of Four Phase 3 Studies: G. Choukroun1, A. Harkavyi2, V. Santos3, A. Jiletcovici3, L. Del Vecchio4 | 1CHU Amiens Picardie and Jules Verne University, Amiens, France, 2Astellas Pharma Europe, Addlestone, UK, 3Astellas Pharma, Inc., Northbrook, USA, 4Sant’Anna Hospital, Como, Italy”. Italian Journal of Medicine 19, no. 1(s1) (August 26, 2025). Accessed September 2, 2025. https://www.italjmed.org/ijm/article/view/2234.